Kawasaki Hastalığı Şok Sendromu

Year 2015, Volume: 15 Issue: 2, 86 - 88, 01.04.2015

Nilüfer Göknar Ayşegül Doğan Demir Selçuk Uzuner Ufuk Erenberk Demet Demirkol

https://doi.org/10.5222/j.child.2015.086

Abstract

Kawasaki hastalığı KH , özellikle 5 yaş altı çocuklarda ortaya çıkan bir multistem vaskülitidir. KH’nın klinik karakteristiği 5 günü geçen açıklanamayan ve uzamış ateşe ek olarak yaygın mukoza inflamasyonu, iki taraflı pürülan olmayan konjuktivit, eritematöz deri döküntüleri, el ve ayaklar üzerinde anjiyoödem ve boyunda lenfadenopatidir. Kawasaki şok sendromu KŞS , KH’nın nadir ve ciddi bir formudur. Komplikasyonları önlemek için çoçuk sağlığı ve hastalıkları uzmanları ve yoğun bakım uzmanlarının KH’nın bu az görülen başvuru şekli ile ilgili farkındalığı olmalıdır. Biz burada Kawasaki şok sendromlu 2 yaşında bir erkek hasta sunduk

Keywords

Kawasaki hastalığı, Kawasaki şok sendromu, koroner arter dilatasyonu

Kawasaki Disease Shock Syndrome

Abstract

Kawasaki disease KD is an acute multisystem vasculitis that occurs principally in children younger than 5 years of age. The clinical characteristics of KD include diffuse mucosal inflammation, bilateral nonpurulent conjunctivi- tis, erythematous skin rashes, angioedema over the hands and feet, and cervical lymphadenopathy in addition to pro- longed and unexplained fever lasting for >5 days.Kawasaki disease shock syndrome KDSS is rare and severe form of KD. Pediatricians and intensive care unit professionals should be aware of this uncommon presentation of KD to prevent complications. Here in we presented a 2-years old male patient with Kawasaki shock syndrome KSS

Keywords

Kawasaki disease, Kawasaki shock syndrome, coronary artery dilatation

References

• Yamamoto l. Kawasaki disease. Pediatr Emerg Care 2003;19:422-4. http://dx.doi.org/10.1097/01.pec.0000101587.65509.90
• Kuo HC, Yang KD, Chang WC, Ger lP, Hsieh KS. Kawasaki disease: an update on diagnosis and treat- ment. Pediatr Neonatol 2012;53:4-11. http://dx.doi.org/10.1016/j.pedneo.2011.11.003
• Kanegaye JT, Wilder mS, molkara D, Frazer J, Pancheri J, Tremoulet AH, et al. Recognition of a Kawasaki disease shock syndrome. Pediatrics 2009; 123:783-9. http://dx.doi.org/10.1542/peds.2008-1871
• Gamez-Gonzalez lB, murata C, munoz-ramirez m, Yamazaki-Nakashimada m. Clinical manifestati- ons associated with Kawasaki disease shock syndrome in Mexican children. Eur J Pediatr 2013;172:337-42. http://dx.doi.org/10.1007/s00431-012-1879-1
• Dominguez Sr, Friedman KF, Seewald r, Anderson mS, Willis l, Glode mP. Kawasaki disease in pediat- ric intensive care unit: a case-control study. Pediatrics 2008;122:786-90. http://dx.doi.org/10.1542/peds.2008-1275
• Chen PS, Chi H, Huang FY, Peng CC, Chen mr, Chiu NC. Clinical manifestations of Kawasaki disease shock syndrome: A case-control syudy. J Microbiol Immunol 2015;48:43-50. http://dx.doi.org/10.1016/j.jmii.2013.06.005
• Gattere P, oıalha m, Dupic l, ıserin F, Bodemer C, lesage F, et al. Kawasaki disease: an unexpected etio- logy of shock and multiple organ dysfunction syndro- me. Intensive Care Med 2012;38:872-8. http://dx.doi.org/10.1007/s00134-012-2473-8
• Bosland A, Arlaud K, rousset-rouvière C, Fouilloux V, Paut o, Dubus JC, et al. Streptococcal toxic shock syndrome or Kawasaki disease? Two case studies of children with group A streptococcal pneumonia empye- ma. Arch Pediatr 2011;18:1310-4.
• lin YJ, Cheng mC, lo mH, Chien SJ. Early diffe- rentiation of Kawasaki disease shock syndrome and toxic shock syndrome in a pediatric intensive care unit. Pediatr Infect Dis J 2015;34:1163-7. http://dx.doi.org/10.1097/INF.0000000000000852